Evidence map›Paper›PMID 37551981›Full record

ReviewRejuvenation research2023

Heterochronic Plasma Transfer: Experimental Design, Considerations, and Technical Challenges.

Victor A Ansere, Matthew P Bubak, Benjamin F Miller, Willard M Freeman

Open access · greenAbstract readReview
In one paragraph

Review in Rejuvenation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Victor A AnsereGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Matthew P BubakAging and Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0003-4953-4671
Benjamin F MillerAging and Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0003-3283-0685
Willard M FreemanGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Oklahoma Medical Research Foundation · US

Funding

GEROSCIENCE TRAINING PROGRAM IN OKLAHOMAT32AG052363 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Benjamin Francis Miller, William Edmund Sonntag · 2017 to 2026
$3.6M
Sex divergence and cell specificity of age-related hippocampal DNA modificationsR01AG059430 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FREEMAN, WILLARD M · 2019 to 2023
$2.7M
Reversing age-related epigenetic changes and characterizing microglia heterogeneity in obesity and agingF99AG079813 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ANSERE, VICTOR AFRIYIE · 2022 to 2024
$51k
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophyI01BX005592 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI MILLER, BENJAMIN FRANCIS · 2022 to 2025
–
BLRD Research Career Scientist Award ApplicationIK6BX006033 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI FREEMAN, WILLARD M · 2022 to 2025
–
BLRD VA I01 BX005592BLRD VA IK6 BX006033NIA NIH HHS F99 AG079813NIA NIH HHS R01 AG059430NIA NIH HHS T32 AG052363
6 · The paper itself

Abstract

Experimental approaches such as Heterochronic Plasma Transfer (HPT) provide insights into the aging process and help identify the factors that impact aging, with the aim of developing anti-aging therapies. HPT involves the transfer of plasma from an animal of one age to an animal of a different age and highlights the effects of the systemic environment on aging. Despite its importance as an aging research tool, HPT is not without limitations and HPT experiments across various studies differ in key experimental designs considerations, presenting a challenge in obtaining comparable outcomes. In this review, we examine the caveats and experimental design considerations of HPT as a research tool. We provide insights into plasma preparation procedures, route of administration, dosing regimen, and appropriate controls to assist investigators in achieving their experimental goals.

Indexed as

ParabiosisResearch DesignAgingAnimalsRejuvenationaginggeroscienceheterochronic blood exchangeneutral blood exchangeparabiosis

Identifiers

PMID37551981
PMCPMC10611967
OpenAlexW4385658440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.